Cargando…
Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
BACKGROUND: In single photon emission computed tomography [SPECT], high specific activity of (111)In-labelled tracers will allow administration of low amounts of tracer to prevent receptor saturation and/or side effects. To increase the specific activity, we studied the effect of the buffer used dur...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292493/ https://www.ncbi.nlm.nih.gov/pubmed/22284727 http://dx.doi.org/10.1186/2191-219X-2-4 |
Sumario: | BACKGROUND: In single photon emission computed tomography [SPECT], high specific activity of (111)In-labelled tracers will allow administration of low amounts of tracer to prevent receptor saturation and/or side effects. To increase the specific activity, we studied the effect of the buffer used during the labelling procedure: NaAc, NH(4)Ac, HEPES and MES buffer. The effect of the ageing of the (111)InCl(3 )stock and cadmium contamination, the decay product of (111)In, was also examined in these buffers. METHODS: Escalating amounts of (111)InCl(3 )were added to 1 μg of the diethylene triamine pentaacetic acid [DTPA]- and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid [DOTA]-conjugated compounds (exendin-3, octreotide and anti-carbonic anhydrase IX [CAIX] antibody). Five volumes of 2-(N-morpholino)ethanesulfonic acid [MES], 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES], NH(4)Ac or NaAc (0.1 M, pH 5.5) were added. After 20 min at 20°C (DTPA-conjugated compounds), at 95°C (DOTA-exendin-3 and DOTA-octreotide) or at 45°C (DOTA-anti-CAIX antibody), the labelling efficiency was determined by instant thin layer chromatography. The effect of the ageing of the (111)InCl(3 )stock on the labelling efficiency of DTPA-exendin-3 as well as the effect of increasing concentrations of Cd(2+ )(the decay product of (111)In) were also examined. RESULTS: Specific activities obtained for DTPA-octreotide and DOTA-anti-CAIX antibody were five times higher in MES and HEPES buffer. Radiolabelling of DTPA-exendin-3, DOTA-exendin-3 and DTPA-anti-CAIX antibody in MES and HEPES buffer resulted in twofold higher specific activities than that in NaAc and NH(4)Ac. Labelling of DTPA-exendin-3 decreased with 66% and 73% for NaAc and NH(4)Ac, respectively, at day 11 after the production date of (111)InCl(3), while for MES and HEPES, the maximal decrease in the specific activity was 10% and 4% at day 11, respectively. The presence of 1 pM Cd(2+ )in the labelling mixture of DTPA-exendin-3 in NaAc and NH(4)Ac markedly reduced the labelling efficiency, whereas Cd(2+ )concentrations up to 0.1 nM did not affect the labelling efficiency in MES and HEPES buffer. CONCLUSIONS: We showed improved labelling of DTPA- and DOTA-conjugated compounds with (111)In in HEPES and MES buffer. The enhanced labelling efficiency appears to be due to the reduced competitive chelation of cadmium. The enhanced labelling efficiency will allow more sensitive imaging of the biomarkers with SPECT. |
---|